CD23 Antigen Density is Related to Serum Gamma Globulin Level, Bone Marrow Reticulin Pattern, and Treatment in B Chronic Lymphocytic Leukemia

References

• Foon K.A., Todd R.F. Immunologic classification of leukemia and lymphoma. Blood 1986; 68: 1–31
   PubMed Web of Science ®Google Scholar
• Freedman A.S., Nadler L.M. B cell develop ment in chronic lymphocytic leukemia. Semin. Hematol. 1987; 24: 230–239
   PubMed Web of Science ®Google Scholar
• Freedman A.S., Nadler L.M. The relationship of chronic lymphocytic leukemia to normal activated B cells. Leukemia and Lymphoma 1990; 1: 293–300
   PubMedGoogle Scholar
• Legac E., Chastang C., Binet J.L., Michel A., Debre P., Merle-Beral H. Proposals for a phenotypic classification of B-chronic lymphocytic leukemia, relationship with prognostic factors. Leukemia and Lymphoma 1991; 5: 53–58, (suppl.)
   PubMed Web of Science ®Google Scholar
• Sarfati M., Fournier S., Christoffersen M., Biron G. Expression of CD23 antigen and its regulation by IL-4 in chronic lymphocytic leukemia. Leuk. Res. 1990; 14: 47–55
   PubMed Web of Science ®Google Scholar
• Merle-Béral H., Blanc C., Chastang C., Debre P. Phenotypic heterogeneity of B and T cell differentiation antigens in B CLL. Eur. J. Haematol. 1988; 41: 197–203
   PubMed Web of Science ®Google Scholar
• Geisler C.H., Larsen J.K., Hansen N.E., Hansen M.M., Christensen B.E., Lund B., Nielsen H., Plesner T., Thorling K., Andersen E., Andersen P.K. Prog nostic importance of flow cytometry phenotyping of 540 con secutive patients with B-cell chronic lymphocytic leukemia. Blood 1991; 78: 1795–1802
   PubMed Web of Science ®Google Scholar
• Dadmarz R., Cawley J.C. Heterogeneity of CLL high CD23 antigen and aIFN receptor expression are features of favourable disease and of cell activation. Br. J. Haematol. 1988; 68: 279–282
   PubMed Web of Science ®Google Scholar
• Kimby E., Mellstedt H., Bjorkholm M., Holm G. Clonal cell surface structures related to differentiation, activation and homing in B-cell chronic lymphocytic leukemia and monoclonal lymphocytosis of unknown significance. Eur. J. Haematol. 1989; 43: 452–459
   PubMed Web of Science ®Google Scholar
• Gibson J., Neville S., Joshua D., Kroninberg H. CD23 antigen expression in CLL. Br. J. Haematol. 1989; 72: 598
   PubMed Web of Science ®Google Scholar
• Barnett D., Reilly J.T. Lack of correlation between cell surface activation antigen expression and clinical stage in B-CLL. Br. J. Haematol. 1989; 73: 572
   PubMed Web of Science ®Google Scholar
• Sarfati M., Bron D., Lagneaux L., Fonteyn C., Frost H., Delespesse G. Elevation of IgE-Binding factors in serum of patients with B-cell derived chronic lymphocytic leukemia. Blood 1988; 71: 94–98
   PubMed Web of Science ®Google Scholar
• Gordon J. CD23: novel disease marker with a split personality. Clin. Exp. Immunol. 1991; 86: 356–359
   PubMed Web of Science ®Google Scholar
• Liu Y.J., Cairns J.A., Holder M.J., Abbot S.D., Jan-Sen K.U., Bonnefoy J.Y., Gordon J., MacLennan I. C. M. Recombinant 25-kDa CD23 and interleukin lα promote the survival of germinal center B cells: evidence for bifurcation in the development of centrocytes rescued from apoptosis. Eur. J. Immunol. 1991; 21: 1107–1114
   PubMed Web of Science ®Google Scholar
• Silber R., Stahl R. Chronic lymphocytic leukemia and related diseases. Hematology4th ed., W.J. Williams, E. Beutler, A.I. Erslev, M.A. Lichtman. McGraw Hill, New York 1990; 1005–1025
   Google Scholar
• Poncelet P., Carayon P. Cytofluorometric quantification of cell-surface antigens by indirect immunofluores-cence using monoclonal antibodies. J. Immunol. Methods 1985; 85: 65–74
   PubMed Web of Science ®Google Scholar
• Poncelet P., Lavabre-Bertrand T., Carayon P. Quantitative phenotypes of B chronic lymphocytic leukaemia B cells established with monoclonal antibodies from the B cell protocol. Leukocyte Typing II, E.L. Reinherz, B.F. Haynes, L.M. Nadler, I.D. Bernstein. Springer-Verlag, New York 1986; vol. 2: 329–343
   Google Scholar
• Genetet N., Grosbois B., Merdrignac G., Poncelet P., Avril Y., Le Carrour M., Bourel D., Leblay R., Genetet B. Quantitative phenotypes of B-CLL cells: a longitudinal study. Leucocyte Typing III, A.J. Mc Michael. Oxford University Press, Oxford 1986; 493–496
   Google Scholar
• Duperray C., Klein B., Dune B. G. M., Zhang X., Jour-Dan M., Poncelet P., Favier F., Vincent C., Brochier J., Lenoir G., Bataille R. Phenotype analysis of human myeloma cell lines. Blood 1989; 73: 566–572
   PubMed Web of Science ®Google Scholar
• Monserrat E., Marques-Pereira J.P., Gallart M.T., Rozman C. Bone marrow histologic patterns and im-munologic findings in B-chronic lymphocytic leukemia. Can cer 1984; 54: 447–451
   Google Scholar
• Binet I.L., Auguier A., Dighiero G., Chastang C., Pi-Guet H., Goasguen I., Vangier G., Potron G., Polona P., Oberling F., Thomas M., Tchemia G., Jacquillat C., Boivin P., Lesty C., Dualt M.T., Gremy F. A new prognostic classification of chronic lymphocytic leukaemia derived from multi-variate survival analysis. Cancer 1981; 48: 198–206
   PubMed Web of Science ®Google Scholar
• Poncelet P., Bikoue A., Lavabre T., Poinas G., Parant M., Duperray C., Sampol J. Quantitative expression of human lymphocytes membrane antigens: definition of normal densities measured in immunocytometry with the QIFI assay. Cytometry 1991, Suppl 5: 418A
   Google Scholar
• Lanier L.L., Warner N.L. Paraformaldehyde fixation of hematopoietic cells for quantitative flow cytometry analysis. J. Immunol. Methods 1981; 47: 25–30
   PubMed Web of Science ®Google Scholar
• Waitz R., Mayer G., Mayer S., Oberling F. Etude de la réticuline dam les syndromes lymphoîdes de la moelleosseuse. Nouv. Rev. Fr. Hématol. 1971; 11: 416–419
   PubMedGoogle Scholar
• Bryon P.A., Fière D., Revol L. Histologie quantitative et ultrastructure des localisations médullaires des hémopathies lymphoides chroniques: corrklation entre réticuline et polymorphisme lymphocytaire. Nouv. Rev. Fr. Hématol. 1971; 11: 408–415
   PubMedGoogle Scholar